Juvenile Myelomonocytic Leukemia
Welcome,         Profile    Billing    Logout  
 18 Companies   31 Products   31 Products   32 Mechanisms of Action   1 Trial   87 News 


12»
  • ||||||||||  Trial primary completion date:  Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer (clinicaltrials.gov) -  May 13, 2016   
    P2,  N=10, Recruiting, 
    Recruiting --> Terminated | Trial primary completion date: Aug 2018 --> Dec 2015; Study was terminated in August 2016 due to replacement by a new study. Trial primary completion date: Sep 2016 --> Mar 2017
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Traumeel (clinicaltrials.gov) -  Jan 5, 2016   
    P=N/A,  N=195, Completed, 
    Recruiting --> Suspended Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation (clinicaltrials.gov) -  Oct 30, 2015   
    P2,  N=12, Active, not recruiting, 
    Active, not recruiting --> Completed | N=47 --> 14 | Trial primary completion date: Sep 2015 --> Dec 2015 Recruiting --> Active, not recruiting | N=18 --> 12 | Trial primary completion date: Jan 2018 --> Apr 2015
  • ||||||||||  Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi, Mylotarg (gemtuzumab ozogamicin) / UCB, PDL, Pfizer
    Enrollment change, Combination therapy:  Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML (clinicaltrials.gov) -  Apr 22, 2015   
    P1,  N=12, Terminated, 
    Active, not recruiting --> Completed | N=88 --> 6 | Trial primary completion date: Sep 2014 --> Dec 2011 N=16 --> 12
  • ||||||||||  Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi, Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Enrollment change, Trial termination, Trial primary completion date:  Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant (clinicaltrials.gov) -  Apr 13, 2015   
    P2,  N=11, Terminated, 
    Trial primary completion date: Mar 2015 --> Sep 2015 N=28 --> 11 | Recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Oct 2014; Replaced by another protocol